Labcorp Holdings Current Ratio 2010-2025 | LH
Current and historical current ratio for Labcorp Holdings (LH) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Labcorp Holdings current ratio for the three months ending June 30, 2025 was 1.50.
| Labcorp Holdings Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-06-30 | $4.09B | $2.72B | 1.50 |
| 2025-03-31 | $3.79B | $2.07B | 1.84 |
| 2024-12-31 | $4.81B | $3.33B | 1.44 |
| 2024-09-30 | $4.91B | $3.41B | 1.44 |
| 2024-06-30 | $3.57B | $4.07B | 0.88 |
| 2024-03-31 | $3.46B | $3.94B | 0.88 |
| 2023-12-31 | $3.77B | $3.23B | 1.17 |
| 2023-09-30 | $3.95B | $2.90B | 1.36 |
| 2023-06-30 | $5.12B | $2.18B | 2.35 |
| 2023-03-31 | $4.70B | $2.89B | 1.63 |
| 2022-12-31 | $4.63B | $3.08B | 1.50 |
| 2022-09-30 | $4.37B | $2.52B | 1.73 |
| 2022-06-30 | $5.03B | $2.64B | 1.90 |
| 2022-03-31 | $5.23B | $2.64B | 1.98 |
| 2021-12-31 | $5.33B | $2.78B | 1.92 |
| 2021-09-30 | $6.02B | $2.89B | 2.08 |
| 2021-06-30 | $5.69B | $2.67B | 2.14 |
| 2021-03-31 | $5.64B | $3.37B | 1.67 |
| 2020-12-31 | $5.13B | $3.08B | 1.67 |
| 2020-09-30 | $4.09B | $3.01B | 1.36 |
| 2020-06-30 | $3.41B | $3.03B | 1.13 |
| 2020-03-31 | $2.89B | $2.46B | 1.18 |
| 2019-12-31 | $2.98B | $2.66B | 1.12 |
| 2019-09-30 | $2.99B | $2.56B | 1.17 |
| 2019-06-30 | $2.85B | $2.50B | 1.14 |
| 2019-03-31 | $2.89B | $2.53B | 1.14 |
| 2018-12-31 | $2.84B | $1.88B | 1.51 |
| 2018-09-30 | $3.27B | $2.11B | 1.56 |
| 2018-06-30 | $3.02B | $2.12B | 1.42 |
| 2018-03-31 | $2.90B | $2.10B | 1.38 |
| 2017-12-31 | $2.73B | $2.19B | 1.25 |
| 2017-09-30 | $2.90B | $1.54B | 1.89 |
| 2017-06-30 | $2.52B | $1.81B | 1.39 |
| 2017-03-31 | $2.49B | $1.75B | 1.42 |
| 2016-12-31 | $2.48B | $1.83B | 1.36 |
| 2016-09-30 | $2.66B | $1.91B | 1.39 |
| 2016-06-30 | $2.64B | $1.27B | 2.08 |
| 2016-03-31 | $2.75B | $1.64B | 1.67 |
| 2015-12-31 | $2.62B | $1.70B | 1.54 |
| 2015-09-30 | $2.71B | $1.84B | 1.47 |
| 2015-06-30 | $2.59B | $1.82B | 1.42 |
| 2015-03-31 | $2.33B | $1.41B | 1.65 |
| 2014-12-31 | $1.69B | $0.98B | 1.73 |
| 2014-09-30 | $1.69B | $0.75B | 2.25 |
| 2014-06-30 | $1.57B | $0.74B | 2.11 |
| 2014-03-31 | $1.42B | $0.75B | 1.89 |
| 2013-12-31 | $1.43B | $0.74B | 1.95 |
| 2013-09-30 | $1.21B | $0.68B | 1.78 |
| 2013-06-30 | $1.15B | $0.66B | 1.75 |
| 2013-03-31 | $1.19B | $0.74B | 1.61 |
| 2012-12-31 | $1.39B | $1.03B | 1.35 |
| 2012-09-30 | $1.46B | $1.12B | 1.30 |
| 2012-06-30 | $1.06B | $0.72B | 1.48 |
| 2012-03-31 | $1.08B | $0.77B | 1.41 |
| 2011-12-31 | $1.06B | $0.73B | 1.45 |
| 2011-09-30 | $1.07B | $0.98B | 1.09 |
| 2011-06-30 | $1.08B | $1.03B | 1.06 |
| 2011-03-31 | $1.15B | $1.20B | 0.96 |
| 2010-12-31 | $1.14B | $1.12B | 1.02 |
| 2010-09-30 | $0.95B | $0.95B | 1.00 |
| 2010-06-30 | $0.92B | $0.90B | 1.02 |
| 2010-03-31 | $0.98B | $0.89B | 1.11 |
| 2009-12-31 | $0.94B | $1.02B | 0.92 |
| 2009-09-30 | $0.98B | $0.60B | 1.62 |
| 2009-06-30 | $1.06B | $0.55B | 1.91 |
| 2009-03-31 | $1.21B | $0.60B | 2.03 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $22.982B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.003B | 27.08 |
| CVS Health (CVS) | United States | $90.597B | 11.27 |
| Elevance Health (ELV) | United States | $69.715B | 9.38 |
| Cencora (COR) | United States | $58.790B | 19.58 |
| DiDi Global (DIDIY) | China | $29.369B | 31.20 |
| Natera (NTRA) | United States | $22.227B | 0.00 |
| BioMerieux (BMXMF) | France | $17.547B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.490B | 0.00 |
| ICON (ICLR) | Ireland | $14.189B | 13.65 |
| Medpace Holdings (MEDP) | United States | $12.736B | 33.71 |
| CochLear (CHEOY) | Australia | $12.699B | 0.00 |
| Solventum (SOLV) | United States | $12.484B | 12.88 |
| Viatris (VTRS) | United States | $12.463B | 4.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.720B | 0.00 |
| Revvity (RVTY) | United States | $10.408B | 18.34 |
| Avantor (AVTR) | United States | $8.563B | 12.56 |
| Sonic Healthcare (SKHHY) | Australia | $7.992B | 0.00 |
| HealthEquity (HQY) | United States | $7.874B | 34.49 |
| Charles River Laboratories (CRL) | United States | $7.606B | 14.43 |
| Bausch + Lomb (BLCO) | Canada | $5.133B | 34.52 |
| Sotera Health (SHC) | United States | $4.525B | 25.29 |
| BrightSpring Health Services (BTSG) | United States | $4.244B | 32.38 |
| KindlyMD (NAKA) | United States | $3.998B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.468B | 79.42 |
| Alignment Healthcare (ALHC) | United States | $3.129B | 0.00 |
| Concentras Parent (CON) | United States | $2.949B | 18.71 |
| Surgery Partners (SGRY) | United States | $2.931B | 36.87 |
| Organon (OGN) | United States | $2.412B | 2.63 |
| Premier (PINC) | United States | $2.106B | 19.53 |
| Progyny (PGNY) | United States | $1.989B | 42.06 |
| Ardent Health (ARDT) | United States | $1.826B | 7.05 |
| PACS (PACS) | United States | $1.788B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.560B | 26.41 |
| Pediatrix Medical (MD) | United States | $1.406B | 9.39 |
| Teladoc Health (TDOC) | United States | $1.270B | 0.00 |
| Omada Health (OMDA) | $1.236B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.159B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.809B | 4.74 |
| AMN Healthcare Services Inc (AMN) | United States | $0.753B | 9.31 |
| CareDx (CDNA) | United States | $0.666B | 12.27 |
| QDM (QDMI) | Hong Kong, SAR China | $0.641B | 110.00 |
| Performant Healthcare (PHLT) | United States | $0.602B | 0.00 |
| Nutex Health (NUTX) | United States | $0.534B | 8.09 |
| Agilon Health (AGL) | United States | $0.510B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.484B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.466B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.465B | 6.98 |
| SBC Medicals (SBC) | United States | $0.438B | 9.61 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.414B | 0.00 |
| Enhabit (EHAB) | United States | $0.405B | 26.63 |
| So-Young (SY) | China | $0.395B | 0.00 |
| Oncology Institute (TOI) | United States | $0.329B | 0.00 |
| LifeMD (LFMD) | United States | $0.298B | 0.00 |
| Beauty Health (SKIN) | United States | $0.263B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.186B | 0.00 |
| DocGo (DCGO) | United States | $0.156B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.135B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| OSR Holdings (OSRH) | United States | $0.010B | 0.00 |
| ModivCare (MODV) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |